n-methyllevallorphan and Constipation

n-methyllevallorphan has been researched along with Constipation* in 1 studies

Other Studies

1 other study(ies) available for n-methyllevallorphan and Constipation

ArticleYear
Levallorphan methyl iodide (SR 58002), a potent narcotic antagonist with peripheral selectivity superior to that of other quaternary compounds.
    Life sciences, 1983, Volume: 33 Suppl 1

    The peripheral selectivity of the newer quaternary narcotic antagonist levallorphan methyl iodide (SR 58002) was found superior in mice to those of the previously available compounds N-allyl levallorphan (CM 32191), N-methyl nalorphine (MNph) and N-methyl naloxone (MNx). SR 58002 and MNph were the most potent (ID50, mg/kg s.c., 3.6 and 3.7) in preventing constipation by s.c. morphine (charcoal meal). Antinociception (hot-plate) of s.c. morphine was completely prevented by MNx, MNph and CM 32191 (ID50, mg/kg s.c., 1.6, 8.6 and 15.2) but only partially antagonized by 30 mg/kg s.c. SR 58002. Constipation elicited centrally by intracerebroventricular (i.c.v.) morphine was prevented by either s.c. MNx or MNph but not by SR 58002 or CM 32191, up to 60 mg/kg.

    Topics: Animals; Constipation; Female; Gastrointestinal Motility; Levallorphan; Mice; Morphine; Naloxone; Structure-Activity Relationship

1983